CN1544042A - 六味地黄滴丸及其制备方法 - Google Patents
六味地黄滴丸及其制备方法 Download PDFInfo
- Publication number
- CN1544042A CN1544042A CNA2003101133479A CN200310113347A CN1544042A CN 1544042 A CN1544042 A CN 1544042A CN A2003101133479 A CNA2003101133479 A CN A2003101133479A CN 200310113347 A CN200310113347 A CN 200310113347A CN 1544042 A CN1544042 A CN 1544042A
- Authority
- CN
- China
- Prior art keywords
- preparation
- substrate
- dry powder
- kidney
- thick paste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 239000006187 pill Substances 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 52
- 229940079593 drug Drugs 0.000 claims abstract description 36
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 29
- 239000000843 powder Substances 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 16
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 13
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 238000009833 condensation Methods 0.000 claims abstract description 5
- 230000005494 condensation Effects 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 5
- 238000000605 extraction Methods 0.000 claims abstract description 4
- 230000004927 fusion Effects 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 239000000758 substrate Substances 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- 238000005516 engineering process Methods 0.000 claims description 14
- -1 Lac Polymers 0.000 claims description 13
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 239000009220 Liuwei Dihuang Decoction Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 229920002545 silicone oil Polymers 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 229920000570 polyether Polymers 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 239000001828 Gelatine Substances 0.000 claims description 6
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 6
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 6
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 claims description 6
- 239000008117 stearic acid Substances 0.000 claims description 6
- 239000007901 soft capsule Substances 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 4
- 229940057995 liquid paraffin Drugs 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 claims description 3
- 230000002879 macerating effect Effects 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000001256 steam distillation Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 239000000341 volatile oil Substances 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims description 2
- 230000026676 system process Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 2
- 239000004519 grease Substances 0.000 abstract 1
- 231100001231 less toxic Toxicity 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 40
- 210000004185 liver Anatomy 0.000 description 17
- 210000000952 spleen Anatomy 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- 238000005553 drilling Methods 0.000 description 5
- 238000013401 experimental design Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000005057 refrigeration Methods 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 238000010579 first pass effect Methods 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 241001269238 Data Species 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 231100000535 infertility Toxicity 0.000 description 3
- 235000015250 liver sausages Nutrition 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010029164 Nephrotic syndrome Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000007962 solid dispersion Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010030216 Oesophagitis Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000020221 Short stature Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043101 Talipes Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 208000006881 esophagitis Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000009874 shenqi Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
聚乙二醇6000 | 25.0 | 92 | <30 | <10 | +++ |
硬脂酸 | 25.0 | 45 | >30 | >10 | + |
硬脂酸钠 | 25.0 | 57 | <30 | >10 | + |
甘油明胶 | 25.0 | 44 | >30 | >10 | + |
单硬脂酸甘油脂 | 25.0 | 66 | <30 | >10 | + |
虫胶 | 25.0 | 38 | >30 | >10 | - |
聚氧乙烯单硬脂酸脂 | 25.0 | 88 | <30 | <10 | ++ |
聚醚 | 25.0 | 67 | <30 | <10 | ++ |
干粉∶基质 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
1∶1 | 50.0 | 61 | <30 | >10 | + |
1∶2 | 33.3 | 73 | <30 | >10 | + |
1∶3 | 25.0 | 93 | <30 | <10 | +++ |
1∶4 | 20.0 | 92 | <30 | <10 | +++ |
1∶5 | 16.7 | 95 | <30 | <10 | +++ |
1∶6 | 14.3 | 96 | <30 | <10 | +++ |
1∶7 | 12.5 | 90 | <30 | <10 | +++ |
1∶8 | 11.1 | 91 | <30 | <10 | +++ |
滴头温度 | 有效成分(%) | 圆整率 | 溶散时限 | 丸重差异 | 硬度 |
(70±2)℃ | 25 | 50 | <30 | <10 | ++ |
(80±2)℃ | 25 | 81 | <30 | <10 | ++ |
(90±2)℃ | 25 | 90 | <30 | <10 | +++ |
(100±2)℃ | 25 | 86 | <30 | <10 | +++ |
冷凝剂 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
液体石蜡 | 20 | 91 | <30 | <10 | +++ |
甲基硅油 | 20 | 93 | <30 | <10 | +++ |
植物油 | 20 | 86 | <30 | <10 | +++ |
冷凝剂温度 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
20→-5℃ | 25 | 94 | <30 | <10 | +++ |
30→-10℃ | 25 | 90 | <30 | <10 | +++ |
40→-15℃ | 25 | 85 | <30 | <10 | +++ |
Claims (7)
- 一.一种六味地黄滴丸,其特征在于:该滴丸是以六味地黄丸处方为基础,按照说明书制备工艺一或二制成干粉或稠膏,再与所选定的基质以一定的比例相混合,经过特定的工艺制备而成;基质可以用聚乙二醇1500~20000、硬脂酸、硬脂酸钠、甘油明胶、单硬脂酸甘油酯、虫胶、聚氧乙烯单硬脂酸脂、聚醚、羧甲基淀粉钠中的一种或几种相混合。
- 二.根据权利要求1所述的六味地黄滴丸,其特征在于:按照说明书制备工艺所得到的干粉或稠膏与所述基质的配比以重量份计为1∶1~8。
- 三.根据权利要求1所述的六味地黄滴丸,其特征在于:按照说明书制备工艺所得到的干粉或稠膏与所述基质的配比更为优选的范围是1∶3~6。
- 四.根据权利要求1所述的六味地黄滴丸,其特征在于:在所述及的基质中,更为优选的是聚乙二醇4000~10000。
- 五.用于权利要求1所述六味地黄滴丸的制备方法,其特征在于由以下几个步骤构成:第一步 原料的提取和制备:1.牡丹皮水蒸汽蒸馏法提取挥发油,蒸馏后的水溶液另器收集,备用。2.熟地、山药、泽泻加水煎煮1次以上,合并煎煮液,滤过。滤液与上述牡丹皮水溶液合并,合并后的溶液置超速离心机上离心10分钟以上,取上清液进行超滤,收集超滤液部分,备用。3.山茱萸3倍量以上,浓度高于50%乙醇浸泡30分钟后,回流提取1次以上,合并提取液,滤过。滤液减压浓缩至无醇味,备用。4.茯苓加水煮沸后,于50℃以上的水浴中温浸1至数次,然后合并浸出液,滤过,滤液备用。5.将以上所得溶液合并,于50~100℃的温度条件下减压浓缩成稠膏,减压干燥,粉碎成细粉,与以上所得丹皮酚结晶混合,得到制造六味地黄滴丸的稠膏或干粉。第二步 将通过第一步制得的稠膏或干粉(或者按照六味地黄软胶囊(国家药品监督管理局-国家药品标准WS3-102(Z-30)-97(Z))和六味地黄口服液(国家药品监督管理局-国家药品标准WS3-B-3774-98)的制法,制备成的稠膏或干粉)以1∶1~8的比例,与作为辅料的基质相混合;基质可以是聚乙二醇1500~20000、硬脂酸、硬脂酸钠、甘油明胶、单硬脂酸甘油脂、虫胶、聚氧乙烯单硬脂酸脂、聚醚、羧甲基淀粉钠等基质中的任意一种或几种相混合而成。第三步 采用水浴、油浴或其它加热方式,将混合物料加热至熔融,搅拌均匀;第四步 置入专用的自制的滴丸机,保持温度为70~100℃。第五步 选择大小合适的滴嘴,以适当的速度,滴入40→-15℃的冷凝剂中;冷凝剂可以是液体石蜡、甲基硅油、植物油中的任意一种或几种。第六步 待收缩成型,取出,去掉表面冷凝剂,干燥,包装,即得。
- 六.按照权利要求5所述制备方法的步骤四,其特征在于:滴制过程中滴丸机滴头的温度更优选的范围是70~90℃。
- 七.按照权利要求5所述制备方法的步骤五,其特征在于:滴制过程中冷凝液的最佳温度范围为20→-5℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310113347 CN1247241C (zh) | 2003-11-12 | 2003-11-12 | 六味地黄滴丸 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310113347 CN1247241C (zh) | 2003-11-12 | 2003-11-12 | 六味地黄滴丸 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1544042A true CN1544042A (zh) | 2004-11-10 |
CN1247241C CN1247241C (zh) | 2006-03-29 |
Family
ID=34336834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310113347 Expired - Lifetime CN1247241C (zh) | 2003-11-12 | 2003-11-12 | 六味地黄滴丸 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1247241C (zh) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1294903C (zh) * | 2005-05-20 | 2007-01-17 | 北京正大绿洲医药科技有限公司 | 治咳枇杷滴丸 |
CN1307985C (zh) * | 2005-05-13 | 2007-04-04 | 北京正大绿洲医药科技有限公司 | 野牡丹滴丸 |
CN1315466C (zh) * | 2005-05-20 | 2007-05-16 | 北京正大绿洲医药科技有限公司 | 紫桔滴丸及其制备方法 |
CN1315465C (zh) * | 2005-05-20 | 2007-05-16 | 北京正大绿洲医药科技有限公司 | 银花芒果滴丸及其制备方法 |
CN1316964C (zh) * | 2005-05-20 | 2007-05-23 | 北京正大绿洲医药科技有限公司 | 止咳喘滴丸及其制备方法 |
CN100348177C (zh) * | 2005-05-13 | 2007-11-14 | 北京正大绿洲医药科技有限公司 | 一种治疗气管炎的苦参滴丸及其制备方法 |
CN100348172C (zh) * | 2005-01-31 | 2007-11-14 | 北京正大绿洲医药科技有限公司 | 一种具有清热作用的田七花叶滴丸及其制备方法 |
CN100348173C (zh) * | 2005-01-31 | 2007-11-14 | 北京正大绿洲医药科技有限公司 | 一种用于清热解毒的银花滴丸及其制备方法 |
CN100358497C (zh) * | 2005-01-31 | 2008-01-02 | 北京正大绿洲医药科技有限公司 | 金莲花滴丸及其制备方法 |
CN100358507C (zh) * | 2005-04-25 | 2008-01-02 | 北京正大绿洲医药科技有限公司 | 大规格六味地黄滴丸及其制备方法 |
CN100364504C (zh) * | 2004-11-12 | 2008-01-30 | 北京正大绿洲医药科技有限公司 | 一种用于治疗妇女病的口服滴丸制剂 |
CN100364506C (zh) * | 2004-12-30 | 2008-01-30 | 北京正大绿洲医药科技有限公司 | 一种用于治疗支气管炎的滴丸及其制备方法 |
CN100367934C (zh) * | 2004-11-12 | 2008-02-13 | 北京正大绿洲医药科技有限公司 | 养阴清肺滴丸 |
CN100398098C (zh) * | 2005-03-21 | 2008-07-02 | 北京正大绿洲医药科技有限公司 | 一种治疗心脾两虚的灵芪加滴丸 |
CN102727712A (zh) * | 2012-06-28 | 2012-10-17 | 江苏颐海药业有限责任公司 | 六味地黄滴丸 |
CN102974124A (zh) * | 2011-11-30 | 2013-03-20 | 洛阳惠中兽药有限公司 | 减压回流技术在中药提取中的应用 |
WO2013155742A1 (zh) * | 2012-04-16 | 2013-10-24 | 江苏颐海药业有限责任公司 | 六味地黄制剂在制备治疗心脏支架术后治疗药物的用途 |
CN104208427A (zh) * | 2014-09-16 | 2014-12-17 | 青岛华仁技术孵化器有限公司 | 用于治疗肾病综合征的药物制剂及其制备方法 |
CN113925950A (zh) * | 2021-11-03 | 2022-01-14 | 余焕舟 | 一种治疗尿毒症的药物组合物及其制备方法与应用 |
-
2003
- 2003-11-12 CN CN 200310113347 patent/CN1247241C/zh not_active Expired - Lifetime
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100367934C (zh) * | 2004-11-12 | 2008-02-13 | 北京正大绿洲医药科技有限公司 | 养阴清肺滴丸 |
CN100364504C (zh) * | 2004-11-12 | 2008-01-30 | 北京正大绿洲医药科技有限公司 | 一种用于治疗妇女病的口服滴丸制剂 |
CN100364506C (zh) * | 2004-12-30 | 2008-01-30 | 北京正大绿洲医药科技有限公司 | 一种用于治疗支气管炎的滴丸及其制备方法 |
CN100358497C (zh) * | 2005-01-31 | 2008-01-02 | 北京正大绿洲医药科技有限公司 | 金莲花滴丸及其制备方法 |
CN100348172C (zh) * | 2005-01-31 | 2007-11-14 | 北京正大绿洲医药科技有限公司 | 一种具有清热作用的田七花叶滴丸及其制备方法 |
CN100348173C (zh) * | 2005-01-31 | 2007-11-14 | 北京正大绿洲医药科技有限公司 | 一种用于清热解毒的银花滴丸及其制备方法 |
CN100398098C (zh) * | 2005-03-21 | 2008-07-02 | 北京正大绿洲医药科技有限公司 | 一种治疗心脾两虚的灵芪加滴丸 |
CN100358507C (zh) * | 2005-04-25 | 2008-01-02 | 北京正大绿洲医药科技有限公司 | 大规格六味地黄滴丸及其制备方法 |
CN100348177C (zh) * | 2005-05-13 | 2007-11-14 | 北京正大绿洲医药科技有限公司 | 一种治疗气管炎的苦参滴丸及其制备方法 |
CN1307985C (zh) * | 2005-05-13 | 2007-04-04 | 北京正大绿洲医药科技有限公司 | 野牡丹滴丸 |
CN1294903C (zh) * | 2005-05-20 | 2007-01-17 | 北京正大绿洲医药科技有限公司 | 治咳枇杷滴丸 |
CN1316964C (zh) * | 2005-05-20 | 2007-05-23 | 北京正大绿洲医药科技有限公司 | 止咳喘滴丸及其制备方法 |
CN1315465C (zh) * | 2005-05-20 | 2007-05-16 | 北京正大绿洲医药科技有限公司 | 银花芒果滴丸及其制备方法 |
CN1315466C (zh) * | 2005-05-20 | 2007-05-16 | 北京正大绿洲医药科技有限公司 | 紫桔滴丸及其制备方法 |
CN102974124A (zh) * | 2011-11-30 | 2013-03-20 | 洛阳惠中兽药有限公司 | 减压回流技术在中药提取中的应用 |
CN102974124B (zh) * | 2011-11-30 | 2015-01-14 | 洛阳惠中兽药有限公司 | 减压回流技术在中药提取中的应用 |
WO2013155742A1 (zh) * | 2012-04-16 | 2013-10-24 | 江苏颐海药业有限责任公司 | 六味地黄制剂在制备治疗心脏支架术后治疗药物的用途 |
CN102727712A (zh) * | 2012-06-28 | 2012-10-17 | 江苏颐海药业有限责任公司 | 六味地黄滴丸 |
CN104208427A (zh) * | 2014-09-16 | 2014-12-17 | 青岛华仁技术孵化器有限公司 | 用于治疗肾病综合征的药物制剂及其制备方法 |
CN113925950A (zh) * | 2021-11-03 | 2022-01-14 | 余焕舟 | 一种治疗尿毒症的药物组合物及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1247241C (zh) | 2006-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1247241C (zh) | 六味地黄滴丸 | |
CN101455812B (zh) | 用于治疗肾虚的中成药滴丸、其制备方法及用途 | |
CN1297288C (zh) | 一种治疗心血管疾病的药物及其制备方法 | |
CN100358507C (zh) | 大规格六味地黄滴丸及其制备方法 | |
CN1634476A (zh) | 麻杏止咳滴丸及其制备方法 | |
CN100358562C (zh) | 川贝枇杷滴丸及其制备方法 | |
CN1634431A (zh) | 一种治疗上呼吸道感染的银黄滴丸 | |
CN1316959C (zh) | 五加参归芪滴丸及其制备方法 | |
CN100358496C (zh) | 一种治疗脑炎、肝昏迷的醒脑静滴丸及其制备方法 | |
CN1634509A (zh) | 一种治疗疼痛的伊痛舒滴丸及其制备方法 | |
CN1292737C (zh) | 一种具有养心安神作用的口服滴丸及其制备方法 | |
CN101623306B (zh) | 凤尾草滴丸及其制造方法 | |
CN100398098C (zh) | 一种治疗心脾两虚的灵芪加滴丸 | |
CN100542515C (zh) | 远志滴丸及其制备方法 | |
CN100344314C (zh) | 一种用于补气养阴的滴丸及其制备方法 | |
CN1679676A (zh) | 六味西红花滴丸及其制备方法 | |
CN1292738C (zh) | 用于补心益肾参茸滴丸及其制备方法 | |
CN1660403A (zh) | 一种用于疏肝健脾、养血调经的消遥滴丸及其制备方法 | |
CN100358502C (zh) | 刺五加滴丸及其制备方法 | |
CN1698820A (zh) | 一种退黄保肝的舒肝宁滴丸及其制备方法 | |
CN100364507C (zh) | 一种用于镇咳去痰的枇杷滴丸及其制备方法 | |
CN1634452A (zh) | 养阴清肺滴丸 | |
CN1325044C (zh) | 一种用于治疗中风类疾病的千草滴丸及其制备方法 | |
CN1294901C (zh) | 一种具有补气活血通络作用的消栓滴丸 | |
CN100443075C (zh) | 生脉滴丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING CHATAL GREEN CONTINENT PHARMACEUTICAL CO., Free format text: FORMER OWNER: BEIJING ZHENGDA OASIS MEDICINE TECHNOLOGY CO., LTD. Effective date: 20120312 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100176 DAXING, BEIJING TO: 101113 TONGZHOU, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120312 Address after: 101113 Beijing Guangyuan Industrial Development Zone in Tongzhou District Street No. 1 Patentee after: Beijing Zhengda oasis Pharmaceutical Co.,Ltd. Address before: 100176, Beijing economic and Technological Development Zone Hongda North Road, 12 innovation building, block B, two Patentee before: Beijing Zhengda oasis Pharmaceutical Technology Co.,Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151113 Address after: 336000 Yuanzhou pharmaceutical industry park, Jiangxi, Yichun Patentee after: JIANGXI JIMINKEXIN PHARMACEUTICAL Co.,Ltd. Address before: 101113 Beijing Guangyuan Industrial Development Zone in Tongzhou District Street No. 1 Patentee before: Beijing Zhengda oasis Pharmaceutical Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20060329 |
|
CX01 | Expiry of patent term |